BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 25, 2010
 |  BC Week In Review  |  Company News  |  Deals

Maxygen, Astellas deal

Perseid Therapeutics LLC, a JV between Maxygen and Astellas, received a $5 million milestone payment from Astellas under an amended 2008 deal to...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >